Global Vaccine justice.

In 2020, coalitions of international, regional and national partners are rapidly forming international coordination to provide strategic, technical and operational support through existing and newly created mechanisms and partnerships.

This effort aims to support increased preparedness and response operations at the national level in the nine main pillars of public health response.

According to WHO media, in 2021 the global and regional support from WHO and its partners must evolve to reflect the needs and capacities of developing countries, respond to the challenges that arise from this new phase of the pandemic at the community level, and realize the full potential of vaccines, therapies, and diagnostics are now available.

The overarching theme running through these priorities is the need to ensure that they reach through strengthened and integrated national and subnational health systems, rather than parallel and vertical efforts.

Investments in health and health security systems are important not only for reducing the impact of COVID-19, but also for strengthening risk management, and preparedness to respond to all health needs, threats and harm from all causes.

Ending the COVID-19 pandemic means controlling transmission in every country and in every context, while setting priorities for managing COVID-19 and regular health services based on a context analysis of all causes of risk of death, no matter how difficult.

those that function for public health, including those under the International Health Regulations, mechanisms for coordination, financing, management, collection and analysis of data, planning and protection of the workforce, management and development, security of service delivery; supply chain management and access to essential medicines and commodities; and supply chain resilience.

In addition, the Operations plan establishes key research and innovation priorities under each operational and technical pillar of the global IMST needed to support the effective implementation of a national action plan to end COVID-19, and establishes the contributions that each of these pillars will accelerate equitable access to vaccines. new, therapeutic and diagnostic alignment with the goals of ACT-Accelerator.

Matching these priorities to coordinated global and regional action will be key to achieving collective strategic goals to reduce transmission, reduce exposure, protect the most vulnerable, reduce morbidity and mortality from all causes, and accelerate equitable access to new vaccines, therapies and diagnostic.

Particular attention will be paid to countries with the most fragile, conflict-affected and most vulnerable or poor countries.

They tend to have low capacity to manage epidemic control and deal with disruptions in service delivery.

Furthermore, through existing humanitarian program channels, support will be provided for vulnerable populations who may not benefit from government programs, because they live in areas that are difficult to reach, or areas that are not under government control.

All countries receive support from the global IMST, but not all countries need the same support, and this need can change radically over time.

At the start of the COVID-19 pandemic in early 2020, decisions on how to allocate and target support to countries are based on a combination of epidemiological data and basic quantitative and contextual information on countries' preparedness and response capacity derived from multiple peer assessment and self-evaluation tools. which exists.

In 2021, this situation has changed. Decisions about when and where support is needed, real strategic planning and adjustment, coordination, and evidence-based decision making are based on access to quality and timely operational and situational tracking data at the national and subnational levels.

Build the future over

The COVID-19 pandemic is in many ways unprecedented, but completely unexpected.

As we focus on our accomplishments, it is important that we learn from past missteps and opportunities, and certainly we want to avoid repeating them.

it means learning from HIV's mistakes, as it took decades for the global poor to gain access to their life-saving medicines only available in high-income countries.

This means learning from the H1N1 pandemic, when the poor have delayed access to vaccines. This means learning from the Ebola epidemic in West Africa,

which shows that many years of hard-earned development achievements can be undone by large-scale epidemics when there is a lack of investment in epidemic preparedness and preparedness, and that epidemic control is dependent on effective community engagement and public trust in government and health services.